WebApr 7, 2024 · Within the collaboration, the Belgium-based companies will use their respective technologies —OncoDNA's whole-genome and whole-transcriptome sequencing capabilities, and myNEO's artificial intelligence and bioinformatics capabilities — to identify targetable neoantigens in individual cancer patients and design mRNA-based vaccines that instruct … WebApr 7, 2024 · While OncoDNA will perform whole genome and whole transcriptome sequencing, myNEO will handle the advanced interpretation of the sequenced data and design the optimal vaccine construct for maximum clinical benefit. The project promises to guide patients through a completely personalized journey.
CureVac Partners with myNEO to Identify Novel Antigen Targets …
Web27 vacatures voor Clinical Research in 9040 Gent op Indeed.com. Solliciteer op vacatures voor Clinical Assistant, Supply Manager, Junior Bioinformatician en ander werk. WebmyNEO has developed an AI-driven platform that produces critical data used to deliver effective immunotherapy treatments by detecting abnormal alterations on tumour cells and investigating these mutations’ immunogenic impact. Use the CB Insights Platform to explore myNEO's full profile. how old is tsuchigomori
myNEO - CrunchBase
WebMay 25, 2024 · Issuer: CureVac / Key word(s): Alliance25.05.2024 / 13:00 The issuer is solely responsible for the content of this announcement.CureVac Partners with myNEO to Identify Novel Antigen Targets for mRNA-Based Cancer Vaccine Development CureVac is broadening its foundation in oncology, leveraging recent progress with its second … WebMay 25, 2024 · myNEO is a Belgian biotech company that focuses on the development of immunotherapies finetuned against the tumour of cancer patients. The core technology to … WebOncology Oncologists diagnose and treat cancers of all types. They use diagnostic tools like biopsies, endoscopies, X-ray and other imaging, nuclear medicine, and blood tests. merge adobe files online free